logo

Gw Pharmaceuticals Plc (GWPH)



Trade GWPH now with
  Date
  Headline
4/12/2018 7:14:37 AM GW Pharmaceuticals And U.S. Subsidiary Greenwich Biosciences To Present Data On Epidiolex At AAN
2/27/2018 7:08:54 AM GW Pharmaceuticals Receives Orphan Drug Designation From EMA For Cannabidiol For Treatment Of Tuberous Sclerosis
12/29/2017 7:03:39 AM GW Pharma Submits MAA In Europe For Epidiolex In Treatment Of Lennox-Gastaut Syndrome And Dravet Syndrome
12/28/2017 7:04:09 AM GW Pharma Announces Acceptance Of NDA Filing For Epidiolex In Treatment Of Lennox-Gastaut Syndrome And Dravet Syndrome
12/13/2017 7:02:16 AM GW Pharma Reacquires Full Rights To Develop And Commercialize Sativex® In U.S.
12/6/2017 9:50:37 PM GW Pharmaceuticals Announces Pricing Of Public Offering Of ADSs Raising Gross Proceeds Of $276 Mln
12/4/2017 7:08:05 AM GW Pharma FY Revenue £8.2 Mln Or $11.0 Mln Vs £10.3 Mln Last Year
12/1/2017 2:51:57 AM In The Spotlight: Zogenix